Trial size CD34 antibodies available in the Antibody Validation Project

Posted by M.Popov on 12th Nov 2020

Trial size CD34 antibodies available in the Antibody Validation Project

Trial size CD34 antibodies available in the Antibody Validation Project

Introduction:

The CD34 gene carries the needed information for synthesising the CD34 molecule which is a protein assumed to have the potential of attaching stem cells to bone marrow. It can also be used as a prognostic marker in favourable head and neck cancer and unfavourable renal cancer. We provide a number of trial sized antibodies, which are suitable for CD34 research purposes, and to help you make the right decision and find the best suited antibody for you, please find the answers to some of the key topics regarding CD34 that we have provided in the links below.

What is CD34?

The protein(CD34 molecule), encoded by this gene may play a role in the attachment of stem cells to the bone marrow extracellular matrix or to stromal cells and is also a single-pass membrane protein which is highly glycosylated and phosphorylated by protein kinase C. It could act as a scaffold for the attachment of lineage specific glycans, allowing stem cells to bind to lectins expressed by stromal cells or other marrow components.

Where is CD34 found?

Primarily CD34 is found in the plasma membrane, cell junctions and nucleoplasm, and it has low tissue and human brain regional specificity, with higher expression in endothelial cells.

What role does CD34 play in disease?

Mutations and overexpressions of CD34 are linked with spindle cell lipoma, neurofibroma and cutaneous fibrous histiocytoma. Furthermore, a CD34 fingerprint immunoreactivity can be used do distinguish neurofibroma from early desmoplastic melanoma.

CD34 antibodies in the Antibody Validation project

St John's Laboratory offers a variety of trial size primary antibodies which target CD34, which are available to try through the Antibody Validation Project. Below we highlight those which have already been reviewed, as well as others which are available to try.

Customer reviewed CD34 antibodies

ModelNameHostClonalityRatingApplication Tested
STJ92122Anti-CD34 antibodyRabbitPolyclonal5IHC

Other CD34 antibodies available in the Antibody Validation Project

ModelNameHostClonalityRecommended Applications
STJ97922Anti-CD34 antibodyMouseMonoclonalWB,IHC,IF,ELISA
ModelNameHostClonalityRecommended Applications
STJ111023Anti-CD34 AntibodyMouseMonoclonalWB,IHC
STJ112692Anti-CD34 AntibodyRabbitMonoclonalWB,IHC,IF,IP
STJ115864Anti-CD34 AntibodyRabbitPolyclonalWB,IHC,IF
STJ180054Anti-CD34 antibodyMouseMonoclonalIHC
STJ22991Anti-CD34 AntibodyRabbitPolyclonalWB,IHC,IF
STJ29565Anti-CD34 AntibodyRabbitPolyclonalWB,IF
STJ72864Anti-CD34 AntibodyGoatPolyclonalELISA,WB

How does the Antibody Validation Project work?

In order to help our customers with their choice of antibody with low risk, we offer one of the largest ranges of primary antibodies with trial size options available.

The Antibody Validation Project works like this.
1. Order your trial size antibody online.
2. Explore its suitability.
3. Return your results by posting them on the product page.
4. Receive a sample refund.

Find out more here.